Antiproliferation effect of commercially brewed coffees on human ovarian cancer cells in vitro

Nutrition and Cancer

Volumn 62, Issue 8, 2010, Pages 1044-1057

  Tai, Joseph ^a   Cheung, Susan ^a   Chan, Edwin ^b   Hasman, David ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA INSTITUTE OF TECHNOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAFFEIC ACID; CAFFEINE; CHLOROGENIC ACID; CISPLATIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREWED COFFEE; CELL PROLIFERATION; COFFEE; CONTROLLED STUDY; DECAFFEINATED COFFEE; HUMAN; HUMAN CELL; OVARY CANCER; REGULAR COFFEE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAFFEIC ACIDS; CAFFEINE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHLOROGENIC ACID; CISPLATIN; COFFEE; COUMARIC ACIDS; DRUG RESISTANCE, NEOPLASM; FEMALE; FOOD HANDLING; HUMANS; INHIBITORY CONCENTRATION 50; OVARIAN NEOPLASMS; QUINIC ACID;

EID: 78249289662     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.492083     Document Type: Article

References (42)

1. Garriguet D: Beverage consumption of Canadian adults. Health Rep 19, 23-29, 2008.
2. Production and Consumption, 2006: Trouble brewing: the changing face of coffee production. http://pubs.wri.org/pubscontent text.cfm?ContentID=1445. Accessed June 21, 2006.
3. Dorea JG and da Costa TH: Is coffee a functional food? Br J Nutr 93, 773-782, 2005.
4. Van Dam RM: Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab 33, 1269-1283, 2008.
5. Lindsay J, Laurin D, Verreault R, Herbert R, Helliwell B, et al.: Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol 156, 445-453, 2002.
6. Nkondjock A: Coffee consumption and the risk of cancer: an overview. Cancer Lett 277, 121-125, 2009.
7. Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, and Rossing MA: Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 17, 712-716, 2008.
8. Hu G, Tuomilehto J, Pakkala E, Hakulinen T, Antikainen R, et al.: Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology 48, 129-136, 2008.
9. Somoza V, Lindenmeier M, Wenzel E, Frank O, Erbersdobler HF, et al.: Activity-guided identification of a chemopreventive compound in coffee beverage using in vitro and in vivo techniques. J Agric Food Chem 51, 6861-6869, 2003.
10. George SE, Ramalakshmi K, and Mohan Rao L: A perception on health benefits of coffee. Crit Rev Food Sci Nutr 48, 464-486, 2008.
11. Farah A, de Paulis T, Trugo LC, and Martin PR: Effect of roasting on the formation of chlorogenic acid lactones in coffee. J Agric Food Chem 53, 1505-1513, 2005.
12. Lopez-Galilea I, DePena MP, and Cid C: Correlation of selected constituents with the total antioxidant capacity of coffee beverages: influence of the brewing procedure. J Agric Food Chem 55, 6110-6117, 2007.
13. Anese M and Nicoli MC: Antioxidant properties of ready-to-drink coffee brews. J Agric Food Chem 51, 942-946, 2003.
14. Natella F, Nardini M, Giannetti I, Dattilo C, and Scaccini C: Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 50, 6211-6216, 2002.
15. Nardini M, Cirillo E, Natella F, and Scaccini C: Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem 50, 5735-5741, 2002.
16. Monteiro M, Farah A, Perrone D, Trugo L, and Danangelo C: Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr 137, 2196-2201, 2007.
17. Schiano MA, Sevin BU, Perras J, Ramos R, Wolloch EH, et al.: In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovariain cell line. Gynecol Oncol 43, 37-45, 1991.
18. Boike GM, Petru E, Sevin BU, Averette HE, Chou TC, et al.: Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line. Gynecol Oncol 38, 315-322, 1990.
19. Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, et al.: Caffeineassisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res 18, 657-666, 1998.
20. Bode AM and Dong Z: The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 247, 26-39, 2007.
21. Coffee consumption statistics in the United States. www.coffeeresearch. org/market/usa.htm Accessed March 9, 2009.
22. British Nutrition Foundation: Coffee. www.nutrition.org.uk Accessed February 27, 2009.
23. Olthof MR, Hollman PC, and Katan MB: Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131, 66-71, 2001.
24. n. J Agric Food Chem 53, 3821-3832, 2005.
25. Henriksson E, Kjellen E, Wahlberg P, Wennerberg J, and Kjellstrom JH: Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays. In Vitro Cell Dev Biol Anim 42, 320-323, 2006.
26. Ozols RF: Systemic therapy for ovarian cancer: current status and new treatments. Semin Oncol 33 (6 Suppl), S3-S11, 2006.
27. Qamar L, Davis R, Anwar A, and Behbakht K: Protein kinase C inhibitor Go6976 augments caffeine-induced reversal of chemoresistance to cisdiamminedichloroplatinum-II (CDDP) in a human ovarian cancer model. Gynecol Oncol 110, 425-431, 2008.
28. Lau CC and Pardee AB: Mechanism by which caffeine potentiate lethality of nitrogen mustard. Proc Natl Acad Sci USA 79, 2942-2946, 1982.
29. Kawahara M, Takahashi Y, Takazawa K, Tsuchiya H, Tomita K, et al.: Caffeine dose-dependently potentiates the antitumor effect of cisplatin in vivo on osteosarcoma. Anticancer Res 28, 1681-1685, 2008. (Pubitemid 351892944)
30. Mattila P, Hellstrom J, and Torronen R: Phenolic acids in berries, fruits, and beverages. J Agric Food Chem 54, 7193-7199, 2006.
31. Pellegrini N, Serafini M, Colombi B, Del Rio D, Salvatore S, et al.: Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr 133, 2812-2819, 2003.
32. Jiang Y, Kusama K, Satoh K, Takayama E, Watanabe S, et al.: Induction of cytotoxicity by chlorogenic acid in human oral tumor cell lines. Phytomedicine 7, 483-491, 2000. (Pubitemid 32005678)
33. Fujioka K and Shibamoto T: Chlorogenic acid and caffeine contents in various commercial brewed coffees. Food Chemistry 106, 217-221, 2008.
34. He Z, Ma WY, Hashimoto T, Bode AM, Yang CS, et al.: Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res 63, 4396-4401, 2003.
35. Fingert HJ, Pu AT, Chen ZY, Googe PB, Alley MC, et al.: In vivo and in vitro enhanced antitumor effects by pentoxifylline in human cancer cells treated with thiotepa. Cancer Res 48, 4375-4381, 1988.
36. Tomita K and Tsuchiya H: Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn J Cancer Res 80, 83-88, 1989. (Pubitemid 20027203)
37. Petru E, Boike G, and Sevin BU: Potentiation of cisplatin cytotoxicity by methylxanthines in vitro. J Cancer Res Clin Oncol 116, 431-433, 1990.
38. Tsuchiya H, Yamamoto N, Asada N, Terasaki T, Kanazawa Y, et al.: Caffeine-potentiated radiochemotherapy and function-saving for highgrade soft tissue sarcoma. Anticancer Res 20, 2137-2143, 2000.
39. Takeuchi A, Tsuchiya H, Yamamoto N, Hayashi K, Yamauchi K, et al.: Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome. Anticancer Res 27, 3489-3495, 2007.
40. Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, et al.: Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 37, 693-703, 1997.
41. Seng KY, Fun CY, Law YL, Lim WM, Fan W, et al.: Population pharmacokinetics of caffeine in healthy male adults using mixed-effect models. J Clin Pharm Ther 34, 103-114, 2009.
42. Azuma K, Ippoushi K, Nakayama M, Ito H, Higashio H, et al.: Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J Agric Food Chem 48, 5496-5500, 2000.